Table 1.
Characteristic | CDR 0 | CDR > 0a | P value |
---|---|---|---|
N | 69 | 29 | |
Age at LP, mean (SD), y | 71.41 (8.62) | 75.1 (5.0) | 0.0337* |
Gender, F/M (% F) | 52/17 (75%) | 17/12 (59%) | 0.6092 |
APOE genotype, % ε4+ | 41% | 59% | 0.4598 |
Education, mean (SD), y | 15.7 (3.0) | 14.0 (3.1) | 0.0128* |
MMSE score (range 0-30), mean (SD) | 29.32 (0.98) | 25.24 (4.15) | <0.0001* |
nWBV, mean (SD), fractional ICV | 0.765 (0.038) | 0.728 (0.033) | <0.0001* |
HC, mean (SD), mm3b | 7084 (793) | 6009 (1236) | <0.0001 |
CSF Aβ40, mean (SD), pg/mL | 10524 (3837) | 10613 (3787) | 0.9164 |
CSF Aβ42, mean (SD), pg/mL | 572 (208) | 472 (186) | 0.0275* |
CSF tau, mean (SD), pg/mL | 334 (180) | 534 (304) | <0.0001* |
CSF ptau181, mean (SD), pg/mL | 61 (27) | 82 (46) | 0.0059* |
CSF tau/Aβ42, mean (SD) | 0.684 (0.559) | 1.363 (1.176) | <0.0002* |
CSF ptau181/Aβ42, mean (SD) | 0.124 (0.087) | 0.211 (0.197) | 0.0030* |
Plasma Aβ40, mean (SD), pg/mLc | 220 (113) | 194 (81) | 0.2942 |
Plasma Aβ42, mean (SD), pg/mLd | 64 (120) | 40 (44) | 0.3137 |
CDR 0.5, n=21; CDR 1, n=8
CDR 0, n=58; CDR > 0, n=28
CDR 0, n=57; CDR > 0, n=27
CDR 0, n=57; CDR > 0, n=27
Abbreviations: APOE, apolipoprotein E; CDR, clinical dementia rating; HC, hippocampal complex (combined left and right hippocampal formation); ICV, intracranial volume; LP, lumbar puncture; N, number; nWBV, normalized whole brain volume; v, volume; y, years;
statistically significant